PTD-DBM 5mg

PTD-DBM Peptide is a peptide-based topical scalp treatment which inhibits the follicle shrinking action of the body’s hormones and enzymes effectively rescuing the follicle at a stem cell level. Treatment with PTD-DBM both prevents hair loss and promotes the growth of new hair follicles.

Many researchers believe that WNT signaling pathways inside of a cell are responsible for hair follicle development and hair regeneration in humans. These pathways are usually made of proteins and they communicate important cell activity and growth signals to various cells throughout our body. Thankfully, PTD-DBM Peptide is able to mimics these WNT signaling proteins, tricks the cells into thinking they’re receiving vital growth signals, and stimulating hair follicle development and regeneration.

The PTD-DBM peptide is a novel wound-healing agent that targets the Wnt/β-catenin signaling pathway. This pathway plays important roles in cutaneous wound healing and dermal fibrosis, but its regulatory mechanism has not been fully elucidated. The PTD-DBM peptide works by targeting the CXXC-type zinc finger protein 5 (CXXC5), which serves as a negative feedback regulator of the Wnt/β-catenin pathway. This protein is reduced in levels in acute wounds, and by targeting it, the PTD-DBM peptide is able to promote wound healing and collagen production. In preclinical studies, the PTD-DBM peptide has shown efficacy in promoting wound healing and reducing scar formation. It is a safe and effective option for treating acute wounds and offers an advantage over other available agents.

PTD-DBM Peptide is a protein transduction domain that helps to bind and block the negative feedback loop of CXXC5 and Dvl. This interaction accelerates cutaneous wound healing and also helps to improve collagen production. Additionally, this peptide can be used in conjunction with valproic acid to further improve the healing process by activating the Wnt/β-catenin pathway.

PTD-DBM Technical Specifications